1. Home
  2. WKHS vs HBIO Comparison

WKHS vs HBIO Comparison

Compare WKHS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$1.77

Market Cap

33.0M

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

SELL

Current Price

$8.70

Market Cap

26.5M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
WKHS
HBIO
Founded
2007
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
33.0M
26.5M
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
WKHS
HBIO
Price
$1.77
$8.70
Analyst Decision
Hold
Analyst Count
2
0
Target Price
★ $3.00
N/A
AVG Volume (30 Days)
★ 296.5K
28.4K
Earning Date
11-16-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 86.92
N/A
EPS
N/A
★ N/A
Revenue
$763,173.00
★ $116,176,000.00
Revenue This Year
$61.80
$4.09
Revenue Next Year
$67.74
$5.22
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.77
$0.40
52 Week High
$11.80
$10.20

Technical Indicators

Market Signals
Indicator
WKHS
HBIO
Relative Strength Index (RSI) 27.07 49.49
Support Level N/A $8.01
Resistance Level $3.40 $10.20
Average True Range (ATR) 0.31 0.58
MACD -0.16 -0.05
Stochastic Oscillator 2.01 29.04

Price Performance

Historical Comparison
WKHS
HBIO

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: